Search

everythinglearnresearchcommunity

for

Search:↓

Adipose-derived stem cells may help with hair loss, but more research is needed.

Troponin I may help detect heart problems in people with Androgenetic Alopecia.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Zinc is important for skin health, and supplements can help treat various skin and hair disorders, but more research is needed for conditions like psoriasis and vitiligo.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

Early hair loss may predict heart disease.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Machine learning and deep learning can effectively diagnose alopecia areata.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

New hair loss treatments could be improved by using combined biological markers.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

A postmenopausal woman with hair loss and hirsutism improved after surgery to remove an ovarian tumor.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

Female and male AGA are different diseases.

Surgeons suggested a standard system for hair transplant methods to improve communication and results.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Transplanting hair from the nape and around the ear to the hairline and temples generally satisfies patients and looks natural.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Hair transplant improves with regenerative medicine and FUE technique.

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.

Men with enlarged prostates often have more severe baldness.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Large prostate links to more hair loss, but age of onset doesn't affect it.